WCLC-话题@MedSci

#WCLC#

72篇内容 | 2521人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1412333, encodeId=5283141233313, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】黄建安教授：重复活检，动态监测：肿瘤是否无所遁形？, objectType=article, longId=116594, objectId=f02811659461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f02811659461, replyNumber=0, likeNumber=0, createdTime=2017-10-19, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f02811659461, moduleTitle=【WCLC 2017】黄建安教授：重复活检，动态监测：肿瘤是否无所遁形？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f02811659461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412332, encodeId=6ba3141233249, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=[WCLC重磅研究]吴一龙教授报告ARCHER 1050研究的前瞻性亚组分析结果, objectType=article, longId=116486, objectId=d55e1164860a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d55e1164860a, replyNumber=0, likeNumber=50, createdTime=2017-10-19, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d55e1164860a, moduleTitle=[WCLC重磅研究]吴一龙教授报告ARCHER 1050研究的前瞻性亚组分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d55e1164860a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412331, encodeId=ac23141233134, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=[WCLC2017]“射频深部热疗+大剂量维生素C”治疗晚期肺癌新研究屡获国际肿瘤学界关注, objectType=article, longId=116471, objectId=edcd1164e192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edcd1164e192, replyNumber=0, likeNumber=79, createdTime=2017-10-19, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edcd1164e192, moduleTitle=[WCLC2017]“射频深部热疗+大剂量维生素C”治疗晚期肺癌新研究屡获国际肿瘤学界关注, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edcd1164e192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412330, encodeId=ec3b14123307c, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=【WCLC 2017】陆舜教授：呋喹替尼联合吉非替尼治疗EGFR突变晚期NSCLC安全性良好，双口服靶向药物潜力值得进一步研究, objectType=article, longId=116321, objectId=ad9011632187, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad9011632187, replyNumber=0, likeNumber=65, createdTime=2017-10-18, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad9011632187, moduleTitle=【WCLC 2017】陆舜教授：呋喹替尼联合吉非替尼治疗EGFR突变晚期NSCLC安全性良好，双口服靶向药物潜力值得进一步研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad9011632187)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412329, encodeId=fd281412329a7, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2017：中国专场座无虚席，向世界传递中国声音, objectType=article, longId=116303, objectId=d3c71163030d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3c71163030d, replyNumber=0, likeNumber=68, createdTime=2017-10-17, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3c71163030d, moduleTitle=WCLC 2017：中国专场座无虚席，向世界传递中国声音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3c71163030d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412328, encodeId=580814123283e, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=世界肺癌大会（WCLC）公布四项重磅研究成果, objectType=article, longId=83789, objectId=569683e89cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=569683e89cb, replyNumber=0, likeNumber=62, createdTime=2016-12-10, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=569683e89cb, moduleTitle=世界肺癌大会（WCLC）公布四项重磅研究成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=569683e89cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412327, encodeId=e17d141232e5a, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2013：龙浩教授发表胸腔镜治肺癌与开胸效果无差异演讲, objectType=article, longId=27408, objectId=8bad2e4084a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bad2e4084a, replyNumber=0, likeNumber=61, createdTime=2013-12-04, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bad2e4084a, moduleTitle=WCLC 2013：龙浩教授发表胸腔镜治肺癌与开胸效果无差异演讲, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bad2e4084a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412326, encodeId=870d1412326bc, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2013：新药“加盟”能否超越含铂双药？No, objectType=article, longId=26420, objectId=7c232642032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c232642032, replyNumber=0, likeNumber=71, createdTime=2013-11-10, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c232642032, moduleTitle=WCLC 2013：新药“加盟”能否超越含铂双药？No, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c232642032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412325, encodeId=f2de141232511, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2013：基于特定基因表达的个体化化疗是否可行？No, objectType=article, longId=26419, objectId=435226419ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=435226419ea, replyNumber=0, likeNumber=82, createdTime=2013-11-10, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=435226419ea, moduleTitle=WCLC 2013：基于特定基因表达的个体化化疗是否可行？No, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=435226419ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412324, encodeId=b3911412324c9, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2013：“watch and wait”模式是否可取？No, objectType=article, longId=26418, objectId=8fbf264186b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fbf264186b, replyNumber=0, likeNumber=97, createdTime=2013-11-10, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fbf264186b, moduleTitle=WCLC 2013：“watch and wait”模式是否可取？No, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fbf264186b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412323, encodeId=cc4d14123239d, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2013：二线治疗是否必须基于驱动基因状态？Yes, objectType=article, longId=26417, objectId=d0102641ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0102641ee4, replyNumber=0, likeNumber=66, createdTime=2013-11-10, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0102641ee4, moduleTitle=WCLC 2013：二线治疗是否必须基于驱动基因状态？Yes, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0102641ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412322, encodeId=a06414123226b, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2013：新型抑制剂治疗克唑替尼失败后 ALK阳性晚期NSCLC, objectType=article, longId=26416, objectId=3e6c264166c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e6c264166c, replyNumber=0, likeNumber=92, createdTime=2013-11-10, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e6c264166c, moduleTitle=WCLC 2013：新型抑制剂治疗克唑替尼失败后 ALK阳性晚期NSCLC, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e6c264166c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412321, encodeId=f86c1412321fa, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2013：基于基因组技术支撑的分子分型和多臂临床试验设计的兴起, objectType=article, longId=26415, objectId=cf3a2641596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf3a2641596, replyNumber=0, likeNumber=65, createdTime=2013-11-10, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf3a2641596, moduleTitle=WCLC 2013：基于基因组技术支撑的分子分型和多臂临床试验设计的兴起, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf3a2641596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412320, encodeId=50391412320ba, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2013：基于驱动基因分型的靶向治疗能显著改善生存, objectType=article, longId=26414, objectId=190b264141b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=190b264141b, replyNumber=0, likeNumber=61, createdTime=2013-11-10, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=190b264141b, moduleTitle=WCLC 2013：基于驱动基因分型的靶向治疗能显著改善生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=190b264141b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412319, encodeId=6e171412319f5, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2013：阿法替尼有效治疗EGFR突变阳性NSCLC新证据, objectType=article, longId=26281, objectId=49c8262817e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49c8262817e, replyNumber=0, likeNumber=60, createdTime=2013-11-08, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49c8262817e, moduleTitle=WCLC 2013：阿法替尼有效治疗EGFR突变阳性NSCLC新证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49c8262817e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1412318, encodeId=be2d1412318ff, content=<a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a>, objectTitle=WCLC 2013：EGFR野生型NSCLC二线治疗中培美曲塞优于吉非替尼（CTONG 0806研究）, objectType=article, longId=26015, objectId=e591260152f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e591260152f, replyNumber=0, likeNumber=56, createdTime=2013-11-01, rootId=0, userName=木头人514, userId=91252863770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e591260152f, moduleTitle=WCLC 2013：EGFR野生型NSCLC二线治疗中培美曲塞优于吉非替尼（CTONG 0806研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e591260152f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

WCLC

2020-05-29

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】黄建安教授：重复活检，动态监测：肿瘤是否无所遁形？

2017-10-19

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

[WCLC重磅研究]吴一龙教授报告ARCHER 1050研究的前瞻性亚组分析结果

2017-10-19

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

[WCLC2017]“射频深部热疗+大剂量维生素C”治疗晚期肺癌新研究屡获国际肿瘤学界关注

2017-10-19

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

【WCLC 2017】陆舜教授：呋喹替尼联合吉非替尼治疗EGFR突变晚期NSCLC安全性良好，双口服靶向药物潜力值得进一步研究

2017-10-18

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2017：中国专场座无虚席，向世界传递中国声音

2017-10-17

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

世界肺癌大会（WCLC）公布四项重磅研究成果

2016-12-10

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2013：龙浩教授发表胸腔镜治肺癌与开胸效果无差异演讲

2013-12-04

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2013：新药“加盟”能否超越含铂双药？No

2013-11-10

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2013：基于特定基因表达的个体化化疗是否可行？No

2013-11-10

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2013：“watch and wait”模式是否可取？No

2013-11-10

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2013：二线治疗是否必须基于驱动基因状态？Yes

2013-11-10

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2013：新型抑制剂治疗克唑替尼失败后 ALK阳性晚期NSCLC

2013-11-10

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2013：基于基因组技术支撑的分子分型和多臂临床试验设计的兴起

2013-11-10

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2013：基于驱动基因分型的靶向治疗能显著改善生存

2013-11-10

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2013：阿法替尼有效治疗EGFR突变阳性NSCLC新证据

2013-11-08

木头人514 (审核中...)

前往app查看评论内容

#WCLC#

WCLC 2013：EGFR野生型NSCLC二线治疗中培美曲塞优于吉非替尼（CTONG 0806研究）

2013-11-01

科室
- - 订阅+
  - 更多科室
工具
服务